|
Cholestyramine Clinical Trials
3 actively recruiting trials across 2 locations
Also known as: Cholybar, Colestyramine, Duolite AP143 Resin, Questran, Questran Light
Pipeline
Phase 1: 2Phase 3: 1
Top Sponsors
- City of Hope Medical Center2
- Sanofi1
Indications
- Cancer2
- Advanced Pancreatic Adenocarcinoma1
- Acute Graft Versus Host Disease1
- Multiple Sclerosis1
- Unresectable Pancreatic Ductal Adenocarcinoma1
Duarte, California2 trials
Gemcitabine and Leflunomide in Patients With Advanced Unresectable Pancreatic Cancer
City of Hope Medical Center
Phase 1
Birmingham, Alabama1 trial
Efficacy and Safety Studies of Frexalimab (SAR441344) in Adults With Relapsing Forms of Multiple Sclerosis
University of Alabama at Birmingham- Site Number : 8401135
Phase 3
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.